Dekorationsartikel gehören nicht zum Leistungsumfang.
Sprache:
Englisch
172,95 €*
Versandkostenfrei per Post / DHL
Lieferzeit 4-7 Werktage
Kategorien:
Beschreibung
Specification of Drug Substances and Products: Development and Validation of Analytical Methods, Second Edition, presents a comprehensive and critical analysis of the requirements and approaches to setting specifications for new pharmaceutical products, with an emphasis on phase-appropriate development, validation of analytical methods, and their application in practice. This thoroughly revised second edition covers topics not covered or not substantially covered in the first edition, including method development and validation in the clinical phase, method transfer, process analytical technology, analytical life cycle management, special challenges with generic drugs, genotoxic impurities, topical products, nasal sprays and inhalation products, and biotechnology products.
The book's authors have been carefully selected as former members of the ICH Expert Working Groups charged with developing the ICH guidelines, and/or subject-matter experts in the industry, academia and in government laboratories.
The book's authors have been carefully selected as former members of the ICH Expert Working Groups charged with developing the ICH guidelines, and/or subject-matter experts in the industry, academia and in government laboratories.
Specification of Drug Substances and Products: Development and Validation of Analytical Methods, Second Edition, presents a comprehensive and critical analysis of the requirements and approaches to setting specifications for new pharmaceutical products, with an emphasis on phase-appropriate development, validation of analytical methods, and their application in practice. This thoroughly revised second edition covers topics not covered or not substantially covered in the first edition, including method development and validation in the clinical phase, method transfer, process analytical technology, analytical life cycle management, special challenges with generic drugs, genotoxic impurities, topical products, nasal sprays and inhalation products, and biotechnology products.
The book's authors have been carefully selected as former members of the ICH Expert Working Groups charged with developing the ICH guidelines, and/or subject-matter experts in the industry, academia and in government laboratories.
The book's authors have been carefully selected as former members of the ICH Expert Working Groups charged with developing the ICH guidelines, and/or subject-matter experts in the industry, academia and in government laboratories.
Inhaltsverzeichnis
PART 1 INTRODUCTION1. Introduction
2. General Principles and Regulatory Considerations: Specifications and Shelf Life Setting
3. General Principles and Regulatory Considerations: Method Development and Validation
4. Application of Quality by Design (QbD) to the Development and Validation of Analytical Methods
5. Analytical Methods in the Clinical Phase of Development
6. Method Transfer
7. Process Analytical Technology PART 2 UNIVERSAL TESTS8. Description and Identification
9. Assay and Impurities: Specifications
10. Assay and Impurities: Method Development and Life-Cycle Management
11. Assay and Impurities: Method Validation
12. Mutagenic Impurities
13. Residual Solvents
14. Inorganic Impurities (Elemental Impurities) PART 3 SPECIFIC TESTS: DRUG SUBSTANCES15. Solid State Characterization
16. Chiral Methods
17. Water Determination PART 4 SPECIFIC TESTS DRUG PRODUCT18. Drug Release: Oral Products
19. Topical Products
20. Extractables and Leachables PART 5 BIOTECHNOLOGY PRODUCTS21. Regulatory Requirements for Setting Drug Substance and Drug Product Specifications
22. Validation of Analytical Methods for Biotechnology Products PART 6 PHARMACOPEIAL METHODS23. Pharmacopeial Methods and Test (Updated) PART 7 BIOLOGICAL FLUIDS24. Biological Fluids
2. General Principles and Regulatory Considerations: Specifications and Shelf Life Setting
3. General Principles and Regulatory Considerations: Method Development and Validation
4. Application of Quality by Design (QbD) to the Development and Validation of Analytical Methods
5. Analytical Methods in the Clinical Phase of Development
6. Method Transfer
7. Process Analytical Technology PART 2 UNIVERSAL TESTS8. Description and Identification
9. Assay and Impurities: Specifications
10. Assay and Impurities: Method Development and Life-Cycle Management
11. Assay and Impurities: Method Validation
12. Mutagenic Impurities
13. Residual Solvents
14. Inorganic Impurities (Elemental Impurities) PART 3 SPECIFIC TESTS: DRUG SUBSTANCES15. Solid State Characterization
16. Chiral Methods
17. Water Determination PART 4 SPECIFIC TESTS DRUG PRODUCT18. Drug Release: Oral Products
19. Topical Products
20. Extractables and Leachables PART 5 BIOTECHNOLOGY PRODUCTS21. Regulatory Requirements for Setting Drug Substance and Drug Product Specifications
22. Validation of Analytical Methods for Biotechnology Products PART 6 PHARMACOPEIAL METHODS23. Pharmacopeial Methods and Test (Updated) PART 7 BIOLOGICAL FLUIDS24. Biological Fluids
Details
Erscheinungsjahr: | 2020 |
---|---|
Medium: | Taschenbuch |
Inhalt: | Kartoniert / Broschiert |
ISBN-13: | 9780081028247 |
ISBN-10: | 0081028245 |
Sprache: | Englisch |
Herstellernummer: | C2018-0-00966-4 |
Autor: | Riley, Christopher M. |
Redaktion: |
Riley, Christopher M.
Rosanske, Thomas W. Reid, George L. |
Auflage: | 2. Aufl. |
Hersteller: |
Elsevier
Elsevier Science & Technology |
Verantwortliche Person für die EU: | Zeitfracht Medien GmbH, Ferdinand-Jühlke-Str. 7, D-99095 Erfurt, produktsicherheit@zeitfracht.de |
Maße: | 32 x 191 x 235 mm |
Von/Mit: | Christopher M. Riley (u. a.) |
Erscheinungsdatum: | 24.07.2020 |
Gewicht: | 1,54 kg |
Inhaltsverzeichnis
PART 1 INTRODUCTION1. Introduction
2. General Principles and Regulatory Considerations: Specifications and Shelf Life Setting
3. General Principles and Regulatory Considerations: Method Development and Validation
4. Application of Quality by Design (QbD) to the Development and Validation of Analytical Methods
5. Analytical Methods in the Clinical Phase of Development
6. Method Transfer
7. Process Analytical Technology PART 2 UNIVERSAL TESTS8. Description and Identification
9. Assay and Impurities: Specifications
10. Assay and Impurities: Method Development and Life-Cycle Management
11. Assay and Impurities: Method Validation
12. Mutagenic Impurities
13. Residual Solvents
14. Inorganic Impurities (Elemental Impurities) PART 3 SPECIFIC TESTS: DRUG SUBSTANCES15. Solid State Characterization
16. Chiral Methods
17. Water Determination PART 4 SPECIFIC TESTS DRUG PRODUCT18. Drug Release: Oral Products
19. Topical Products
20. Extractables and Leachables PART 5 BIOTECHNOLOGY PRODUCTS21. Regulatory Requirements for Setting Drug Substance and Drug Product Specifications
22. Validation of Analytical Methods for Biotechnology Products PART 6 PHARMACOPEIAL METHODS23. Pharmacopeial Methods and Test (Updated) PART 7 BIOLOGICAL FLUIDS24. Biological Fluids
2. General Principles and Regulatory Considerations: Specifications and Shelf Life Setting
3. General Principles and Regulatory Considerations: Method Development and Validation
4. Application of Quality by Design (QbD) to the Development and Validation of Analytical Methods
5. Analytical Methods in the Clinical Phase of Development
6. Method Transfer
7. Process Analytical Technology PART 2 UNIVERSAL TESTS8. Description and Identification
9. Assay and Impurities: Specifications
10. Assay and Impurities: Method Development and Life-Cycle Management
11. Assay and Impurities: Method Validation
12. Mutagenic Impurities
13. Residual Solvents
14. Inorganic Impurities (Elemental Impurities) PART 3 SPECIFIC TESTS: DRUG SUBSTANCES15. Solid State Characterization
16. Chiral Methods
17. Water Determination PART 4 SPECIFIC TESTS DRUG PRODUCT18. Drug Release: Oral Products
19. Topical Products
20. Extractables and Leachables PART 5 BIOTECHNOLOGY PRODUCTS21. Regulatory Requirements for Setting Drug Substance and Drug Product Specifications
22. Validation of Analytical Methods for Biotechnology Products PART 6 PHARMACOPEIAL METHODS23. Pharmacopeial Methods and Test (Updated) PART 7 BIOLOGICAL FLUIDS24. Biological Fluids
Details
Erscheinungsjahr: | 2020 |
---|---|
Medium: | Taschenbuch |
Inhalt: | Kartoniert / Broschiert |
ISBN-13: | 9780081028247 |
ISBN-10: | 0081028245 |
Sprache: | Englisch |
Herstellernummer: | C2018-0-00966-4 |
Autor: | Riley, Christopher M. |
Redaktion: |
Riley, Christopher M.
Rosanske, Thomas W. Reid, George L. |
Auflage: | 2. Aufl. |
Hersteller: |
Elsevier
Elsevier Science & Technology |
Verantwortliche Person für die EU: | Zeitfracht Medien GmbH, Ferdinand-Jühlke-Str. 7, D-99095 Erfurt, produktsicherheit@zeitfracht.de |
Maße: | 32 x 191 x 235 mm |
Von/Mit: | Christopher M. Riley (u. a.) |
Erscheinungsdatum: | 24.07.2020 |
Gewicht: | 1,54 kg |
Sicherheitshinweis